欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/2986/002
药品名称Cefepime MIP 2 g
活性成分
    • cefepime dihydrochloride 2.0 g
剂型Powder for solution for infusion/injection
上市许可持有人MIP Pharma GmbH Kirkeler Str. 41, 66440 Blieskastel Germany
参考成员国 - 产品名称Netherlands (NL)
Cefepime MIP 2 g, poeder voor oplossing voor injectie of infusie
互认成员国 - 产品名称
    • Germany (DE)
      Cefepim MIP 2 g Pulver zur Herstellung einer Injektions- bzw. Infusionslösung
    • Denmark (DK)
    • Austria (AT)
      Cefepim-MIP 2 g Pulver zur Herstellung einer Injektions-/Infusionslösung
    • Spain (ES)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Cefepim MIP Pharma
    • Latvia (LV)
      Cefepime MIP 2 g pulveris injekciju/infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Cefepime MIP 2 g milteliai injekciniam ar infuziniam tirpalui
    • Estonia (EE)
      CEFEPIME MIP
    • Hungary (HU)
    • Bulgaria (BG)
      Cefepime MIP
    • Czechia (CZ)
      Cefepim MIP 2 g
    • Romania (RO)
      Cefepima MIP 2 g pulbere pentru soluţie injectabilă / perfuzabilă
    • Slovakia (SK)
许可日期2014/11/27
最近更新日期2024/04/03
药物ATC编码
    • J01DE01 cefepime
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase